APA (7th ed.) Citation

Yafang, L., Jin, D., Chong, L., Yiping, H., & Qunying, W. (2025, March). Comparative efficacy and safety of vedolizumab and antitumor necrosis factor alfa in patients with inflammatory bowel diseases: A meta‑analysis. Acta Pharmaceutica.

Chicago Style (17th ed.) Citation

Yafang, Li, Ding Jin, Lu Chong, Hong Yiping, and Wang Qunying. "Comparative Efficacy and Safety of Vedolizumab and Antitumor Necrosis Factor Alfa in Patients with Inflammatory Bowel Diseases: A Meta‑analysis." Acta Pharmaceutica Mar. 2025.

MLA (9th ed.) Citation

Yafang, Li, et al. "Comparative Efficacy and Safety of Vedolizumab and Antitumor Necrosis Factor Alfa in Patients with Inflammatory Bowel Diseases: A Meta‑analysis." Acta Pharmaceutica, Mar. 2025.